Author

Brandy M. Quarles

Observed names: Brandy Quarles, Quarles, Brandy M.

Institution: Augusta University

Observed institutions: Augusta University, Louis Stokes Cleveland VA Medical Center, Case Western Reserve University, University of Maryland, College Park

OpenAlex ID: A5083604411

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

2017 · James F Howard, Kimiaki Utsugisawa, et al. · The Lancet Neurology · 847

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

2023 · Vera Bril, Vera Bril, et al. · The Lancet Neurology · 295

Clinical features of LRP4 /agrin‐antibody–positive myasthenia gravis: A multicenter study

2020 · Michael H. Rivner, Brandy M. Quarles, et al. · Muscle & Nerve · 88

Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients

2016 · Michael H. Rivner, Siyang Liu, et al. · Muscle & Nerve · 55

Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis

2021 · Zheng Yu, Meiying Zhang, et al. · Neurology · 35

The NEALS primary lateral sclerosis registry

2020 · Sabrina Paganoni, Fabiola De Marchi, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 17

Anti-Sulfoglucuronosyl Paragloboside Antibody

2016 · Dongpei Li, Seigo Usuki, et al. · ASN NEURO · 6

Amyotrophic Lateral Sclerosis Clinical Research Site Operations: Emerging Challenges and Potential Solutions From Multiple Sites in the US

2025 · Erica Scirocco, Sarah D. Luppino, et al. · Muscle & Nerve · 1

Clinical and demographic features of LRP4 positive myasthenia gravis patients (P5.4-040)

2019 · Siva Pesala, Mazen M. Dimachkie, et al. · Neurology · 1

Works count: 10

Citation count: 1,345

H-index: 6

I10-index: 6